JPH1045538A - Trichogen - Google Patents
TrichogenInfo
- Publication number
- JPH1045538A JPH1045538A JP8220458A JP22045896A JPH1045538A JP H1045538 A JPH1045538 A JP H1045538A JP 8220458 A JP8220458 A JP 8220458A JP 22045896 A JP22045896 A JP 22045896A JP H1045538 A JPH1045538 A JP H1045538A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- hair
- trichogen
- water
- growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001615463 Trichogenes Species 0.000 title abstract 5
- 239000000284 extract Substances 0.000 claims abstract description 46
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000003960 organic solvent Substances 0.000 claims abstract description 11
- 239000000810 peripheral vasodilating agent Substances 0.000 claims abstract description 6
- 229960002116 peripheral vasodilator Drugs 0.000 claims abstract description 6
- 230000003779 hair growth Effects 0.000 claims description 56
- 210000004209 hair Anatomy 0.000 claims description 31
- 239000000463 material Substances 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 23
- 241000196324 Embryophyta Species 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 10
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 abstract description 5
- RZMKWKZIJJNSLQ-UHFFFAOYSA-M carpronium chloride Chemical compound [Cl-].COC(=O)CCC[N+](C)(C)C RZMKWKZIJJNSLQ-UHFFFAOYSA-M 0.000 abstract description 3
- 229950003631 carpronium chloride Drugs 0.000 abstract description 3
- 241000726094 Aristolochia Species 0.000 abstract description 2
- 244000025254 Cannabis sativa Species 0.000 abstract description 2
- BBFQZRXNYIEMAW-UHFFFAOYSA-N aristolochic acid I Chemical compound C1=C([N+]([O-])=O)C2=C(C(O)=O)C=C3OCOC3=C2C2=C1C(OC)=CC=C2 BBFQZRXNYIEMAW-UHFFFAOYSA-N 0.000 abstract description 2
- 241000046617 Aristolochia debilis Species 0.000 abstract 2
- 241000758795 Aristolochiaceae Species 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 238000000967 suction filtration Methods 0.000 abstract 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 238000004519 manufacturing process Methods 0.000 description 17
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 10
- 230000001256 tonic effect Effects 0.000 description 10
- 238000000605 extraction Methods 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 235000014134 echinacea Nutrition 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 241001234760 Aedes japonicus Species 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 229930003427 Vitamin E Natural products 0.000 description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- -1 parabens Substances 0.000 description 5
- 239000000419 plant extract Substances 0.000 description 5
- 235000019165 vitamin E Nutrition 0.000 description 5
- 229940046009 vitamin E Drugs 0.000 description 5
- 239000011709 vitamin E Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- 244000133098 Echinacea angustifolia Species 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 210000004761 scalp Anatomy 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- 240000004530 Echinacea purpurea Species 0.000 description 3
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 3
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical compound [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 230000037380 skin damage Effects 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- HAUGRYOERYOXHX-UHFFFAOYSA-N Alloxazine Chemical compound C1=CC=C2N=C(C(=O)NC(=O)N3)C3=NC2=C1 HAUGRYOERYOXHX-UHFFFAOYSA-N 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 2
- 241000219793 Trifolium Species 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 229950004580 benzyl nicotinate Drugs 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000012676 herbal extract Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 229950004864 olamine Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 238000011735 C3H mouse Methods 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 101800004637 Communis Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 206010063412 Gestational oedema Diseases 0.000 description 1
- 241000255967 Helicoverpa zea Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000223785 Paramecium Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000256248 Spodoptera Species 0.000 description 1
- 241000256251 Spodoptera frugiperda Species 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- ICUTUKXCWQYESQ-UHFFFAOYSA-N triclocarban Chemical compound C1=CC(Cl)=CC=C1NC(=O)NC1=CC=C(Cl)C(Cl)=C1 ICUTUKXCWQYESQ-UHFFFAOYSA-N 0.000 description 1
- 229960001325 triclocarban Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は新規な発毛・育毛料
に関し、詳しくは発毛・育毛効果に優れ、かつ長期にわ
たる使用に十分耐えうる安全性を有する発毛・育毛料を
提供せんとするものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel hair growth / hair restoration material, and more particularly, to provide a hair growth / hair restoration material having excellent hair growth / hair growth effects and having sufficient safety to withstand long-term use. To do.
【0002】[0002]
【従来の技術】従来から提供されている発毛・育毛料に
は各種の生薬エキスあるいは各種の化合物などが配合さ
れてきた。例えば生薬エキスとしてはヨクイニン、カシ
ュウ等の抽出エキス(特公平1−13451号公報、特
開平2−48514号公報等参照)など、また化合物と
してはビタミンE、アロキサジン、ピリジンN−オキシ
ド、アデノシン−3’,5’−サイクリックモノホスフ
ェート等(特開昭−64−56608号公報、特開平−
1−261321号公報、特開平2−204406号公
報等参照)などが挙げられる。2. Description of the Related Art Various herbal medicine extracts or various compounds have been blended with hair growth and hair-growth materials that have been provided so far. For example, as herbal extracts, extracts such as Yokuinin, Kashi, etc. (see Japanese Patent Publication No. 1-14511, JP-A No. 2-48514, etc.), and compounds include vitamin E, alloxazine, pyridine N-oxide, adenosine-3. ', 5'-cyclic monophosphate, etc. (JP-A-64-56608, JP-A-
1-261321, JP-A-2-204406, etc.).
【0003】[0003]
【発明の解決しようとする課題】ところが、これまでに
提供された発毛・育毛料には上記の例に挙げたとおり、
各種の生薬エキスおよび各種の化合物が適用されている
が、顕著な効果を示すものは殆どなく、また、ある程度
の効果を有するものには皮膚炎を起こす程刺激が強く、
連続使用が困難である等の欠点があった。However, the hair-growth / hair-growth agents provided so far are as follows.
Various herbal extracts and various compounds have been applied, but few have a remarkable effect, and those having a certain effect have strong irritation to cause dermatitis,
There are drawbacks such as difficulty in continuous use.
【0004】本発明は、このような実状に鑑みてなされ
たものであって、発毛・育毛効果に優れ、かつ長期にわ
たる使用に十分耐えうる安全性を備えた発毛・育毛料を
提供することを課題とする。[0004] The present invention has been made in view of such circumstances, and provides a hair growth and fostering material that is excellent in hair growth and fostering effects and has sufficient safety to withstand long-term use. That is the task.
【0005】[0005]
【課題を解決するための手段】本発明者は、上記課題を
解決するため鋭意研究を重ねた結果、ウマノスズクサ科
に属する特定の植物から得られた抽出エキスが優れた発
毛・育毛効果を有し、且つ使用時における安全性上の問
題もないことを見いだし、斯かる知見に基づき本発明の
完成に至った。Means for Solving the Problems The inventors of the present invention have conducted intensive studies to solve the above-mentioned problems, and as a result, an extract obtained from a specific plant belonging to the family Echinacea has excellent hair growth and hair growth effects. In addition, they have found that there is no safety problem during use, and have completed the present invention based on such findings.
【0006】すなわち、本発明は、ウマノスズクサ全草
から好ましくは水溶性有機溶媒または含水水溶性有機溶
媒で抽出して得られた抽出エキスを好適には0.001
〜10重量%の範囲で含有することを特徴とする発毛・
育毛料に関する。[0006] That is, the present invention provides an extract preferably obtained by extracting from a whole plant of Echinacea purpurea preferably with a water-soluble organic solvent or a water-containing water-soluble organic solvent.
Hair growth characterized by containing in the range of 10% by weight
Regarding hair restoration materials.
【0007】また本発明は、上記の発毛・育毛料中に更
に皮膚末梢血管拡張剤を含有する発毛・育毛料に関す
る。[0007] The present invention also relates to a hair growth and fostering material further comprising a skin peripheral vasodilator in the above hair growth and fostering material.
【0008】以下、本発明を詳細に説明する。まず、本
発明に適用されるウマノスズクサ(学名:Aristolochia d
ebilis Sieb.et Zucc)とは、本州中部以南から九州、中
国大陸中・南部に分布するウマノスズクサ科ウマノスズ
クサ属に属する無毛の多年生つる草本である。これまで
漢方では、茎や葉などの全草(地上茎)は天仙藤と呼ばれ
妊娠水腫や胃薬に用いられ、また果実は馬兜鈴と呼ばれ
咳どめや去痰に用いられ、更に根(地下茎)の乾燥物は青
木香(セイモッコウ)と呼ばれ、解毒、腸炎、下痢、腹
痛に利用されることが知られていた。このうち青木香に
ついては、一部育毛効果が見いだされ毛髪料として応用
することが提案されている(特開平7-215826号公報)が、
天仙藤や馬兜鈴については毛髪料に使用されたことはな
く、特に天仙藤に顕著な発毛・育毛効果があることにつ
いては、本発明者によって初めて見出されたものであ
る。The present invention will be described in detail below. First, the horse-tailed weed (scientific name: Aristolochia d) applied to the present invention.
ebilis Sieb.et Zucc) is a hairless perennial vine that belongs to the genus Echinacea, which belongs to the genus Echinacea, distributed in the southern and southern parts of Honshu, Kyushu, and the central and southern parts of the Chinese mainland. Until now, in Chinese medicine, the whole plant (ground stem) such as stems and leaves is called Tensento and used for gestational edema and stomach medicine, and the fruit is called horse helmet bell and used for cough deterrent and expectorant, and root ( The dried material of the rhizome is called incense Aoki and is known to be used for detoxification, enteritis, diarrhea, and abdominal pain. Of these, Kaoru Aoki has been found to have some hair-growth effects and has been proposed to be applied as a hair material (Japanese Patent Application Laid-Open No. 7-215826).
Tensento and horse bells have never been used as a hair material, and it was discovered by the present inventor for the first time that Tensenfuji has a remarkable hair growth and hair-growth effect.
【0009】次に、上記のウマノスズクサ全草から本発
明に係る抽出エキスを得るには、植物体を乾燥あるいは
そのまま粉砕したものを、抽出溶媒例えばメタノール、
エタノール、プロパノール、ブタノール等の一価アルコ
ール、1,3−ブチレングリコール、プロピレングリコ
ール等の多価アルコール、またはアセトン、テトラヒド
ロフラン、ジオキサン等の水溶性有機溶媒、または前記
一価アルコール、多価アルコールまたはアセトン、テト
ラヒドロフラン、ジオキサン等を好ましくは50重量%
以上含有する含水水溶性有機溶媒、更にはヘキサン、ヘ
プタン、シクロヘキサン、酢酸エチル等の非水溶性有機
溶媒を用いて抽出するが、好ましくは水溶性有機溶媒ま
たは含水水溶性有機溶媒をもちいるのが良い。Next, in order to obtain the extracted extract according to the present invention from the above-mentioned whole horsegrass, the plant is dried or ground as it is, and the extract solvent such as methanol,
Monohydric alcohols such as ethanol, propanol and butanol; polyhydric alcohols such as 1,3-butylene glycol and propylene glycol; or water-soluble organic solvents such as acetone, tetrahydrofuran and dioxane; or the above monohydric alcohols, polyhydric alcohols or acetone , Tetrahydrofuran, dioxane, etc., preferably at 50% by weight
Extraction using a water-containing water-soluble organic solvent containing the above, further using a water-insoluble organic solvent such as hexane, heptane, cyclohexane, and ethyl acetate, preferably using a water-soluble organic solvent or a water-containing water-soluble organic solvent. good.
【0010】具体的な方法としては、ウマノスズクサ全
草100gを抽出溶媒0.5〜5lを用い、室温〜抽出
溶媒の沸点の温度で、室温時7〜10日間、加温時4〜
8時間、1〜2回、温浸抽出する。これら抽出液を合わ
せ、吸引濾過後、溶媒を除くために減圧下濃縮し、粘稠
あるいは乾固した抽出エキスを得る。得られた抽出エキ
スをそのまま、あるいは適宜の溶媒等で溶解分散希釈せ
しめ基剤中に配合し本発明の発毛・育毛料を得る。[0010] As a specific method, 100 g of the whole plant of Spodoptera communis is extracted from 0.5 to 5 liters of the extraction solvent at room temperature to the boiling point of the extraction solvent at room temperature for 7 to 10 days and at the heating temperature of 4 to 4.
Extract by digestion once or twice for 8 hours. These extracts are combined, filtered with suction, and then concentrated under reduced pressure to remove the solvent to obtain a viscous or dried extract. The obtained extract is dissolved or dispersed and diluted with an appropriate solvent or the like as it is, and then mixed with a base to obtain the hair growth and hair growth material of the present invention.
【0011】ここで本発明に係る発毛・育毛料の有効成
分として含有されるウマノスズクサ全草抽出エキスの含
有量は好ましくは0.001〜10重量%、特に好まし
くは0.05〜5重量%である。含有量が0.001重
量%未満では育毛効果が低下し、また10重量%を越え
る量では安定性が低下する。[0011] Here, the content of the extract of whole horseshoe clover whole plant extract contained as an active ingredient of the hair growth and fostering agent according to the present invention is preferably 0.001 to 10% by weight, particularly preferably 0.05 to 5% by weight. Is. If the content is less than 0.001% by weight, the hair-growth effect is reduced, and if it exceeds 10% by weight, the stability is reduced.
【0012】次に、本発明の発毛・育毛料では上記のウ
マノスズクサ全草抽出エキスに加えて皮膚末梢血管拡張
剤を含有せしめた場合には更に好ましい発毛・育毛効果
を有する。このような皮膚末梢血管拡張剤としては、例
えば塩化カルプロニウム、ニコチン酸ベンジル、ビタミ
ンE、ビタミンEアセテート、ビタミンEリノレート、
ビタミンEニコチネート、トウガラシチンキ等が挙げら
れ、これらのうちの一種又は二種以上が使用される。Next, the hair growth and hair growth agent of the present invention has a more preferable hair growth and hair growth effect when it contains a skin peripheral vasodilator in addition to the above extract of Scutellaria baicalensis. Examples of such skin peripheral vasodilators include carpronium chloride, benzyl nicotinate, vitamin E, vitamin E acetate, vitamin E linoleate,
Vitamin E nicotinate, pepper tincture, and the like, and one or more of these are used.
【0013】また、本発明の発毛・育毛料には、前記の
ウマノスズクサ全草抽出エキス、皮膚末梢血管拡張剤の
ほか通常発毛・育毛料に用いられる添加剤、例えばヒノ
キチオール、カチオン界面活性剤、パラベン等の殺菌
剤、l−メントール等の清涼剤、炭化水素類、ロウ類、
油脂類、エステル類、高級脂肪酸、高級アルコール等の
油分、その他界面活性剤、香料、色素、抗酸化剤、紫外
線防御剤、アルコール類、pH調整剤、および水などを
配合することができる。[0013] The hair growth and fostering composition of the present invention includes, in addition to the extract of the whole plant of Echinacea purpurea, the peripheral vasodilator of the skin, and additives usually used for hair growth and fostering, such as hinokitiol and cationic surfactant. , Sterilizing agents such as parabens, cooling agents such as l-menthol, hydrocarbons, waxes,
Oils such as oils and fats, esters, higher fatty acids, higher alcohols, etc., and other surfactants, fragrances, pigments, antioxidants, ultraviolet protective agents, alcohols, pH adjusters, water and the like can be blended.
【0014】本発明の発毛・育毛料としては種々の剤
型、例えばヘアトニック、シャンプー、リンス、ポマー
ド、ヘアローション、ヘアクリーム、ヘアトリートメン
トなどが挙げられ、常法に従って調製される。The hair growth and hair-growth agent of the present invention includes various dosage forms such as hair tonic, shampoo, conditioner, pomade, hair lotion, hair cream, hair treatment and the like, and they are prepared according to a conventional method.
【0015】[0015]
【発明の実施の形態】ここで本発明に係るウマノスズク
サ全草抽出エキスの製造例を示す。 製造例1.ウマノスズクサの全草乾燥物100gを70
%エタノール1lで室温にて10日間浸漬抽出し、濾紙
で残渣を濾別し、濾液をエバポレーションして乾固し、
抽出エキスを得た。(収率3.1%)BEST MODE FOR CARRYING OUT THE INVENTION Here, an example of the production of the extract of the whole herbaceae extract according to the present invention will be shown. Production Example 1. 70 g of dried whole plant of Aedes japonicus
% Ethanol at room temperature for 10 days, the residue was filtered off with filter paper, and the filtrate was evaporated to dryness.
An extract was obtained. (Yield 3.1%)
【0016】製造例2.ウマノスズクサの全草乾燥物1
00gをエタノール1lに浸漬し、ソックスレー抽出器
に移し、加温抽出を8時間行なう。その後冷却して濾紙
で残渣を濾別し、濾液をエバポレーションして乾固し、
抽出エキスを得た。(収率3.8%)Manufacturing Example 2. Dried whole plant of Aedes japonicus 1
00 g is immersed in 1 L of ethanol, transferred to a Soxhlet extractor, and subjected to warm extraction for 8 hours. After cooling, the residue was filtered off with filter paper, the filtrate was evaporated to dryness,
An extract was obtained. (3.8% yield)
【0017】製造例3.ウマノスズクサの全草乾燥物1
00gをアセトン1lに浸漬し、ソックスレー抽出器に
移し、加温抽出を8時間行なう。その後冷却して濾紙で
残渣を濾別し、濾液をエバポレーションして乾固し、抽
出エキスを得た。(収率2.7%)Manufacturing Example 3. Dried whole plant of Aedes japonicus 1
00 g is immersed in 1 liter of acetone, transferred to a Soxhlet extractor, and subjected to warm extraction for 8 hours. After cooling, the residue was filtered off with filter paper, and the filtrate was evaporated to dryness to obtain an extracted extract. (Yield 2.7%)
【0018】製造例4.ウマノスズクサの全草乾燥物1
00gをブタノール1lに浸漬し、ソックスレー抽出器
に移し、加温抽出を8時間行なう。その後冷却して濾紙
で残渣を濾別し、濾液をエバポレーションして乾固し、
抽出エキスを得た。(収率2.9%)Production Example 4. Dried whole plant 1
00g is immersed in 1 l of butanol, transferred to a Soxhlet extractor, and subjected to warm extraction for 8 hours. After cooling, the residue is filtered off with filter paper, the filtrate is evaporated to dryness,
An extract was obtained. (Yield 2.9%)
【0019】製造例5.ウマノスズクサの全草乾燥物1
00gをプロピレングリコール:蒸留水=1:1の抽出
溶媒1lに浸漬し、ソックスレー抽出器に移し、加温抽
出を8時間行なう。その後冷却して濾紙で残渣を濾別
し、濾液をエバポレーションして乾固し、抽出エキスを
得た。(収率3.2%)Production Example 5. Dried whole plant of Aedes japonicus 1
00 g is immersed in 1 liter of an extraction solvent of propylene glycol: distilled water = 1: 1, transferred to a Soxhlet extractor, and subjected to warm extraction for 8 hours. After cooling, the residue was filtered off with filter paper, and the filtrate was evaporated to dryness to obtain an extract. (Yield 3.2%)
【0020】製造例6.ウマノスズクサの全草乾燥物1
00gを酢酸エチル1lで室温にて10日間浸漬抽出
し、濾紙で残渣を濾別し、濾液をエバポレーションして
乾固し、抽出エキスを得た。(収率1.9%)Production Example 6. Dried whole plant of Aedes japonicus 1
00 g was immersed and extracted with 1 L of ethyl acetate at room temperature for 10 days, the residue was filtered off with a filter paper, and the filtrate was evaporated to dryness to obtain an extract. (Yield 1.9%)
【0021】比較製造例1.青木香100gをエタノー
ル1lに浸漬し、ソックスレー抽出器に移し、加温抽出
を8時間行なう。その後冷却して濾紙で残渣を濾別し、
濾液をエバポレーションして乾固し、抽出エキスを得
た。(収率3.1%)Comparative Production Example 1. 100 g of Aoki incense is immersed in 1 liter of ethanol, transferred to a Soxhlet extractor, and subjected to warm extraction for 8 hours. After cooling, the residue was filtered off with filter paper,
The filtrate was evaporated to dryness to obtain an extract. (Yield 3.1%)
【0022】次に、上記の如くして得られたウマノスズ
クサ全草抽出エキスのマウスの毛成長に及ぼす効果につ
いての比較試験を実施した。Next, a comparative test was carried out on the effect of the extract of the whole plant of Astragalus vulgaris obtained as described above on hair growth in mice.
【0023】「マウス毛成長評価試験」 (1)試料 本 発 明 品 :ウマノスズクサ全草抽出エキス(製造例
2)を5%含有する70%エタノール水分散液 比 較 品 1 :ビタミンEを1%含有する70%エタノ
ール水分散液 比 較 品 2 :青木香抽出エキス(比較製造例1)を5
%含有する70%エタノール水分散液 コントロール:70%エタノール水溶液"Mouse hair growth evaluation test" (1) Sample This invention: 70% ethanol aqueous dispersion containing 5% of the extract of the whole plant of Spodoptera frugiperda (Production Example 2) Comparative product 1: Vitamin E 1% 70% ethanol aqueous dispersion containing Comparative product 2: 5 extract of Aoki incense extract (Comparative Production Example 1)
% Aqueous solution containing 70% ethanol Control: 70% aqueous ethanol solution
【0024】(2)試験方法 9週令のC3Hマウスを用い、1群を10匹とし、4群
作り、これらの背部を2.0×2.0cmの広さに除毛し
た後、翌日除毛部位に各試料を0.04g塗布した後、
16日目に当該部位の毛成長の密度を色差計を用いて黒
色増加度として評価した。その結果を表1に示す。(2) Test method Using 9-week-old C3H mice, one group consisting of 10 mice was made into 4 groups, and the backs of these groups were shaved to a size of 2.0 × 2.0 cm, and then removed the next day. After applying 0.04g of each sample to the hair part,
On day 16, the density of hair growth at the site was evaluated as the degree of increase in blackness using a color difference meter. Table 1 shows the results.
【0025】[0025]
【表1】 [Table 1]
【0026】表1の結果から明らかなように、本発明に
係るウマノスズクサ全草抽出エキスでは、コントロール
と比較してL値が減少し、黒色度が増加していることが
分かる。一方、比較品1のビタミンE及び比較品2の青
木香抽出エキスではコントロールと比較してL値の減少
が殆ど認められなかった。これは本発明に係るウマノス
ズクサ全草抽出エキスが毛根を刺激、毛包周囲の血行を
より盛んにし、代謝を活発にした結果と推察される。As is clear from the results shown in Table 1, in the extract of the whole herbaceous extract according to the present invention, the L value is decreased and the blackness is increased as compared with the control. On the other hand, in the vitamin E of the comparative product 1 and the extract of incense Aoki of the comparative product 2, almost no decrease in the L value was observed as compared with the control. This is presumed to be the result of the extract of whole horseshoe clover whole grass extract according to the present invention stimulating hair roots, increasing blood circulation around hair follicles, and activating metabolism.
【0027】[0027]
【実施例】以下、実施例により本発明を更に説明する。
尚、配合量は重量部である。 実施例1〜3.ヘアトニック 下記表2に示す成分及び配合組成を用い、各成分を加温
溶解し、可溶化してヘアトニックを調製した。The present invention will be further described with reference to the following examples.
In addition, the compounding amount is a weight part. Examples 1-3. Hair Tonic Using the ingredients and blending composition shown in Table 2 below, each ingredient was dissolved by heating and solubilized to prepare a hair tonic.
【0028】[0028]
【表2】 [Table 2]
【0029】「ヒト発毛・育毛評価試験」 (1)試料 本発明品:実施例1〜3のヘアトニック 比 較 品:実施例1のヘアトニックからウマノスズクサ
全草抽出エキス(製造例2)を除いた(水を増量)ヘア
トニック"Human hair growth / hair growth evaluation test" (1) Sample The product of the present invention: hair tonic of Examples 1 to 3 Comparative product: Extract of whole plant extract of Echinacea purpurea from the hair tonic of Example 1 (Production Example 2) Removed (increased water) Hair tonic
【0030】(2)試験方法 薄毛症、脱毛症を訴える20名のパネラーを各5名ずつ
4群に分け、各試料を用いて6ケ月間の長期連用試験を
実施した。適用方法は通常のトニック使用法と同様一日
2回、頭部にまんべんなく塗布する方法を用いた。また
評価は使用開始後3ケ月目と6ケ月目に行ない、うぶ
毛、硬毛が増えてきたと感じた被験者がどの程度増えた
かを計測した。更に、テスト終了時に頭皮の状態の改善
や、ふけの発生の減少についても申告してもらった。そ
の結果を表3に示す。(2) Test Method Twenty panelists, each complaining of alopecia and alopecia, were divided into 4 groups of 5 each, and a long-term continuous test for 6 months was performed using each sample. As an application method, a method of evenly applying to the head twice a day was used as in the case of using a normal tonic. The evaluation was performed at the third and sixth months after the start of use, and the number of subjects who felt that the amount of downy hair and hard hair had increased was measured. In addition, at the end of the test, they were asked to improve their scalp condition and reduce dandruff. Table 3 shows the results.
【0031】[0031]
【表3】 [Table 3]
【0032】表3の結果から明らかなように、本発明の
発毛・育毛料は、何れもうぶ毛を生じた人、硬毛を生じ
た人が増加していることから発毛効果が認められた。ま
た、テスト終了時に頭皮の状態が改善され、ふけの発生
の減少を申告した人が、実施例1では4名、実施例2で
は3名数えられた。このことから本発明の発毛・育毛料
には育毛効果も認められた。更に、使用テスト期間中に
何れのパネラーにも頭皮の状態の悪化、炎症性の反応等
の皮膚障害は全く観察されなかったことから、安全性も
高いことが確認された。As is evident from the results in Table 3, the hair growth and hair growth preparation of the present invention has a hair growth effect because the number of people who have developed alveoli and those who have hard hair have increased. Was given. At the end of the test, the number of persons who reported improvement in scalp condition and reduction of dandruff generation in Example 1 was 4 and in Example 2 was 3. From this, the hair growth / hair growth material of the present invention was also confirmed to have a hair growth effect. Further, it was confirmed that the safety was high because no skin damage such as deterioration of the scalp condition or inflammatory reaction was observed in any panel during the use test period.
【0033】 実施例4.ヘアトニック (A)ウマノスズクサ全草抽出エキス(製造例4) 3.0 メントール 0.2 ビタミンE 0.05 塩化カルプロニウム 0.1 (B)エタノール 50.0 (C)プロピレングリコール 5.0 ビタミンB2 0.5 酵母抽出液(核酸含有) 0.5 グリチルリチンジカリウム 0.3 塩酸ジフェンヒドラミン 0.3 メチルパラベン 0.2 (D)精製水 39.75 (E)香料 0.1Embodiment 4 FIG. Hair tonic (A) Extract of Whole Grassroots Extract (Preparation Example 4) 3.0 Menthol 0.2 Vitamin E 0.05 Carpronium chloride 0.1 (B) Ethanol 50.0 (C) Propylene glycol 5.0 Vitamin B2 0.5 Yeast extract (containing nucleic acid) 0.5 Glycyrrhizin dipotassium 0.3 Hydrochloric acid Diphenhydramine 0.3 Methyl paraben 0.2 (D) Purified water 39.75 (E) Fragrance 0.1
【0034】(製法)(B)に(A)を溶かしておき、これ
に(C)を溶解した(D)および(E)を加えてヘアトニック
を調製した。(Production method) (A) was dissolved in (B), and (D) and (E) in which (C) was dissolved were added thereto to prepare a hair tonic.
【0035】 実施例5.ヘアトリートメント (A)流動パラフィン 2.0 メチルポリシロキサン(10cs) 2.0 セタノール 4.0 ウマノスズクサ全草抽出エキス(製造例5) 4.5 (B)塩化ステアリルトリメチルアンモニウム 3.0 塩化ジステアリルジメチルアンモニウム 0.5 プロピレングリコール 5.0 ピロクトンオラミン 0.25 精製水 40.0 (C)加水分解コラーゲン 0.5 ヒアルロン酸 0.01 ウシ胎盤抽出エキス 0.5 精製水 37.19 塩酸ジフェンヒドラミン 0.25 メチルパラベン 0.2 (D)香料 0.1 Embodiment 5 Hair treatment (A) Liquid paraffin 2.0 Methyl polysiloxane (10 cs) 2.0 Cetanol 4.0 Extract of whole bollworm extract (Preparation Example 5) 4.5 (B) Stearyl trimethyl ammonium chloride 3.0 Distearyl dimethyl ammonium chloride 0.5 Propylene glycol 5.0 Pyroctone olamine 0.25 Purified water 40.0 (C) Hydrolyzed collagen 0.5 Hyaluronic acid 0.01 Bovine placenta extract 0.5 Purified water 37.19 Diphenhydramine hydrochloride 0.25 Methyl paraben 0.2 (D) Fragrance 0.1
【0036】(製法)(A)および(B)をそれぞれ80℃
に加温し、両者を混合して乳化する。その後40℃付近
まで冷却し、その時点で(C)を添加し、更に(D)を添加
しヘアトリートメントを調製した。(Preparation method) (A) and (B) were each heated to 80 ° C.
The mixture is heated to 2 and mixed to emulsify. After that, the mixture was cooled to around 40 ° C., at which point (C) was added, and (D) was further added to prepare a hair treatment.
【0037】 実施例6.ヘアシャンプー (A)ラウリル硫酸トリエタノールアミン 10.0 ラウリル硫酸ナトリウム 5.0 ヤシ油ジエタノールアミド 2.0 プロピレングリコール 5.0 ピロクトンオラミン 0.25 ニコチン酸ベンジル 0.1 ウマノスズクサ全草抽出エキス(製造例3) 1.0 (B)トリクロロカルバニリド 0.25 精製水 76.3 (C)香料 0.1 Embodiment 6 Hair shampoo (A) Triethanolamine lauryl sulfate 10.0 Sodium lauryl sulfate 5.0 coconut oil diethanolamide 2.0 Propylene glycol 5.0 Pyrocton olamine 0.25 Benzyl nicotinate 0.1 Uranus japonicus whole plant extract (Production Example 3) 1.0 (B) Trichlorocarbanilide 0.25 Purified water 76.3 (C) Fragrance 0.1
【0038】(製法)(A)を80℃にて混合し、その後
40℃付近まで冷却して(B)を添加し、更に(C)を添加
しヘアシャンプーを調製した。(Preparation method) (A) was mixed at 80 ° C., then cooled to about 40 ° C., (B) was added, and (C) was further added to prepare a hair shampoo.
【0039】 実施例7.ヘアリンス (A)流動パラフィン 0.5 メチルポリシロキサン(10cs) 0.5 セタノール 2.0 塩化ステアリルトリメチルアンモニウム 3.0 ウマノスズクサ全草抽出エキス(製造例2) 2.0 (B)1,3−ブチレングリコール 5.0 精製水 40.0 塩酸ジフェンヒドラミン 0.25 (C)グリチルリチンジカリウム 0.25 精製水 46.4 (D)香料 0.1 Embodiment 7 Hair rinse (A) Liquid paraffin 0.5 Methylpolysiloxane (10 cs) 0.5 Cetanol 2.0 Stearyltrimethylammonium chloride 3.0 Echinacea japonicus whole plant extract (Production Example 2) 2.0 (B) 1,3-butylene glycol 5.0 Purified water 40.0 Diphenhydramine hydrochloride 0.25 (C ) Glycyrrhizin dipotassium 0.25 Purified water 46.4 (D) Fragrance 0.1
【0040】(製法)(A)および(B)をそれぞれ80℃
に加温し、その時点で混合して乳化する。その後40℃
付近まで冷却し、(C)を添加し更に(D)を添加しヘアリ
ンスを調製した。(Manufacturing method) (A) and (B) are each at 80 ° C.
The mixture is warmed to, and mixed at that point to emulsify. Then 40 ° C
After cooling to near, (C) was added and then (D) was added to prepare a hair rinse.
【0041】 実施例8.ヘアクリーム (A)ウマノスズクサ全草抽出エキス(製造例1) 2.5 ワセリン 7.0 ミツロウ 8.0 流動パラフィン 37.0 ポリオキシエチレン(20E.O.)セチルエーテル 3.0 グリセリルモノステアレート 2.0 ビタミンEニコチネート 0.1 (B)精製水 34.6 プロピレングリコール 5.0 塩酸ジフェンヒドラミン 0.2 グリチルリチンジカリウム 0.2 エチルパラベン 0.3 (C)香料 0.1Embodiment 8 FIG. Hair cream (A) Extract of whole plant of Paramecium japonicum (Preparation example 1) 2.5 Vaseline 7.0 Beeswax 8.0 Liquid paraffin 37.0 Polyoxyethylene (20E.O.) cetyl ether 3.0 Glyceryl monostearate 2.0 Vitamin E nicotinate 0.1 (B) Purified water 34.6 Propylene glycol 5.0 Diphenhydramine hydrochloride 0.2 Dipotassium glycyrrhizin 0.2 Ethyl paraben 0.3 (C) Fragrance 0.1
【0042】(製法)(A)を80℃にて混合溶解し、次
に予め80℃に加熱しておいた(B)を(A)に徐々に加え
クリーム状とした。その後40℃まで冷却し、(C)を添
加してヘアクリームを調製した。(Production method) (A) was mixed and dissolved at 80 ° C., and then (B) which had been heated to 80 ° C. was gradually added to (A) to form a cream. Thereafter, the mixture was cooled to 40 ° C., and (C) was added to prepare a hair cream.
【0043】 実施例9.ヘアトニック (A)ウマノスズクサ全草抽出エキス(製造例6) 0.5 サリチル酸 0.3 メントール 0.2 トウガラシチンキ 0.01 (B)エタノール 60.0 (C)グリセリン 5.0 (D)精製水 33.89 (E)香料 0.1Embodiment 9 Hair tonic (A) Extract of whole plant extract of Aedes japonicus (Preparation Example 6) 0.5 Salicylic acid 0.3 Menthol 0.2 Pepper tincture 0.01 (B) Ethanol 60.0 (C) Glycerin 5.0 (D) Purified water 33.89 (E) Fragrance 0.1
【0044】(製法)(B)に(A)を溶かしておき、これ
に(C)を溶解した(D)および(E)を加えてヘアトニック
を調製した。(Production method) (A) was dissolved in (B) and (D) and (E) in which (C) was dissolved were added to this to prepare a hair tonic.
【0045】上記実施例4〜9で得られた本発明の発毛
・育毛料について、実施例1〜3と同様の又は準じる方
法で発毛・育毛効果の検定を行ったところ、何れも優れ
た効果を示し、また頭皮の状態の悪化、炎症性の反応等
の皮膚障害は全く観察されなかった。The hair growth and hair growth agents of the present invention obtained in Examples 4 to 9 above were tested for hair growth and hair growth effects by the same method as in Examples 1 to 3 or a similar method. No skin damage such as deterioration of the scalp condition and inflammatory reaction was observed at all.
【0046】[0046]
【発明の効果】本発明によれば、優れた育毛・発毛効果
を有すると共に、長期連用による皮膚障害等も認められ
ず安全性に優れた発毛・育毛料を提供することができ
る。EFFECTS OF THE INVENTION According to the present invention, it is possible to provide a hair-growth / hair-growth material which has an excellent hair-growth / hair-growth effect and which is excellent in safety without causing skin damage due to long-term continuous use.
Claims (4)
することを特徴とする発毛・育毛料。1. A hair-growth / hair-growth material containing an extract of the whole plant of Euphausiaceae.
水溶性有機溶媒で抽出されたものである請求項1に記載
の発毛・育毛料。2. The hair growth and fostering composition according to claim 1, wherein the extract is extracted with a water-soluble organic solvent or a water-containing water-soluble organic solvent.
重量%である請求項1または2の何れかに記載の発毛・
育毛料。3. The content of the extract is 0.001-10.
3% by weight.
Hair restoration.
剤を含有する請求項1から3の何れかに記載の発毛・育
毛料。4. The hair growth / hair growth material according to claim 1, wherein the hair growth / hair growth material contains a skin peripheral vasodilator.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8220458A JPH1045538A (en) | 1996-08-02 | 1996-08-02 | Trichogen |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8220458A JPH1045538A (en) | 1996-08-02 | 1996-08-02 | Trichogen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH1045538A true JPH1045538A (en) | 1998-02-17 |
Family
ID=16751441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8220458A Pending JPH1045538A (en) | 1996-08-02 | 1996-08-02 | Trichogen |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH1045538A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002363057A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Melanin production inhibitor or cosmetic composition |
-
1996
- 1996-08-02 JP JP8220458A patent/JPH1045538A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002363057A (en) * | 2001-06-08 | 2002-12-18 | Ichimaru Pharcos Co Ltd | Melanin production inhibitor or cosmetic composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3527584B2 (en) | Hair restorer / hair restorer | |
| JP3742767B2 (en) | Hair conditioner consisting of extracts of Asagaokakaraksa and other herbal extracts | |
| JP2938253B2 (en) | Hair growth and hair growth fees | |
| JPH1045541A (en) | Trichogen | |
| JPH1045538A (en) | Trichogen | |
| JPH11158042A (en) | Trichogen | |
| KR0154648B1 (en) | Hair growth and restoration promoter | |
| JP2534010B2 (en) | Hair growth and hair growth materials | |
| JPH1045542A (en) | Trichogen | |
| JP2002234812A (en) | Cosmetic | |
| JP3744757B2 (en) | Cosmetics | |
| JP4391043B2 (en) | Hair nourishing agent containing Nanyang purple extract | |
| JPH11171733A (en) | Hair restoring and growing agent | |
| JP3744758B2 (en) | Cosmetics | |
| JPH1045540A (en) | Trichogen | |
| JPH0948712A (en) | Hair growing and fostering agent | |
| JPH11171730A (en) | Hair restoring and growing agent | |
| JPH11171731A (en) | Hair restoring and growing agent | |
| JP2914589B2 (en) | Hair growth and hair growth fees | |
| JP3714836B2 (en) | Cosmetics | |
| JPH09241133A (en) | Hair-growing agent | |
| JP2938254B2 (en) | Hair growth and hair growth fees | |
| JPH06100421A (en) | Trichogenous and hair-growing agent | |
| JPH11158045A (en) | Trichogen | |
| JPH09241136A (en) | Hair growth and hair growth fees |